Tianjin Medical University Second Hospital
4 clinical trials · 4 recruiting · OTHER
Trials by Tianjin Medical University Second Hospital
RECRUITINGPhase 2NCT07172386
Preoperative Therapy of Super-selective Tumor Artery Embolization Combined With Toripalimab and Axitinib in Advanced RCC
This is a phase II study to determine the efficacy and safety of Super-selective tumor artery embolization combined with toripalimab and axitinib as treatment for patients with...
Sponsor: Tianjin Medical University Second HospitalEnrolling: 401 location
Renal Cell Carcinoma (RCC)
RECRUITINGNCT07441499
Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma
Application of Multi-Component Liquid Biopsy (ctDNA, utDNA, Exosomes, and Protein Biomarkers in Blood and Urine) for Auxiliary Diagnosis, Therapeutic Response Evaluation, and...
Sponsor: Tianjin Medical University Second HospitalEnrolling: 3001 location
Urothelial Carcinoma (UC)Bladder (Urothelial, Transitional Cell) CancerLiquid Biopsy
RECRUITINGNCT07180212
Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer
Non-muscle-invasive bladder cancer (NMIBC) is usually treated with surgery to remove the tumor (transurethral resection of bladder tumor, or TURBT), often followed by...
Sponsor: Tianjin Medical University Second HospitalEnrolling: 3602 locations
Bladder CancerLiquid BiopsyCystoscopy
RECRUITINGNCT06031636
Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in Patients With Advanced Malignant Pleural Mesothelioma
The purpose of this study is to evaluate the efficacy and safety of Oncolytic Adenovirus(H101) combined with PD-1 inhibitor in patients with advanced malignant pleural...
Sponsor: Tianjin Medical University Second HospitalEnrolling: 151 location
Malignant Pleural Mesothelioma, Advanced